Entropy as a Measure of Myocardial Tissue Heterogeneity in Patients With Ventricular Arrhythmias.

ABSTRACT

OBJECTIVES: The authors investigated the incremental prognostic value of entropy, a novel measure of myocardial tissue heterogeneity by cardiac magnetic resonance (CMR) imaging in patients presenting with ventricular arrhythmias (VAs). BACKGROUND: CMR can characterize myocardial areas serving as arrhythmogenic substrate. METHODS: Consecutive patients undergoing CMR imaging for VAs were followed for major adverse cardiac events (MACEs) defined by all-cause death, incident VAs requiring therapy, or heart failure hospitalization. Entropy was derived from the probability distribution of pixel signal intensities of the left ventricular (LV) myocardium. RESULTS: A total of 583 patients (age 54 ± 15 years, female 39%, left ventricular ejection fraction [LVEF] 54 ± 13%) were followed for a median of 4.4 years and experienced 141 MACEs. Entropy showed strong unadjusted association with MACE (HR 1.88; 95% CI 1.63-2.17; P < 0.001). In a multivariable model including LVEF, QRS duration, late gadolinium enhancement, and presenting arrhythmia, entropy maintained independent association with MACE (HR 1.61; 95% CI 1.32-1.96; P < 0.001). Entropy was further significantly associated with MACE in patients without myocardial scar (HR 2.43; 95% CI 1.55-3.82; P < 0.001) and in those presenting with nonsustained VAs (HR 2.16; 95% CI 1.43-3.25; P < 0.001). Addition of LV entropy to the baseline multivariable model significantly improved model performance (C-statistic improvement 0.725 to 0.754; P = 0.003) and risk reclassification. CONCLUSIONS: In patients with VAs, CMR-assessed LV entropy was independently associated with MACE and provided incremental prognostic value, on top of LVEF and late gadolinium enhancement. LV entropy assessment may help risk stratification in patients with absence of myocardial scar or with nonsustained VAs.